Our law firm is investigating and monitoring ongoing developments of Gilead Sciences HIV treatment drugs such as Truvada, Viread, Atripla, Complera, and Stribild. Learn more about Gilead TDF HIV drugs lawsuits.
Gilead Sciences delayed the release of a safer HIV treatment to extend its profitable patent, according to internal documents, resulting in lawsuits filed from thousands …
Gilead Delayed Launch of HIV Medication to Maximize Profits, Documents Indicate Read More »
According to new research presented at the Conference on Retroviruses and Opportunistic Infections, people taking tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) drugs specifically for PrEP experienced bone …
New Research Suggests Bone Loss More Likely Among Consistent PrEP Users Read More »
Tenofovir, a tenofovir disoproxil fumarate (TDF) drug, treats HIV infections, and since 2012, has been used as pre-exposure prophylaxis (PrEP) for HIV. However, TDF drugs …
Plaintiffs’ firm Grant & Eisenhofer is liaison counsel in a coordinated proceeding filed by plaintiffs injured by harmful HIV medications manufactured by Gilead Sciences, Inc. Lawsuits allege …
Cases Moving Forward in Truvada Lawsuit Concerning Kidney and Bone Problems Read More »
Personal injury lawsuits, filed on behalf of hundreds of patients injured by Gilead’s HIV medications containing tenofovir disoproxil fumarate (TDF) antiviral medications, are slated to …
